Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal ropivacaine vs ropivacaine + dexmedetomidine for post–sleeve gastrectomy pain
IRCT20151221025641N6Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative pain comparing Intraperitoneal ropivacaine with Intraperitoneal ropivacaine + dexmedetomidine (2 arms). Primary endpoint: Postoperative pain reduction. Started Apr 2023; status: completed.
02
Drugs
ropivacainedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20151221025641N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151221025641N6.